Rechercher | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Affichage: 1 result.

- Article de périodique
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.
Charles, Julie Chaperot, Laurence Hannani, Dalil Bruder Costa, Juliana Templier, Isabelle Trabelsi, Sabiha Gil, Hugo Moisan, Anaick Persoons, Virginie Hegelhofer, Harald Schir, Edith Quesada, Jean-Louis Mendoza, Christophe Aspord, Caroline Manches, Olivier Coulie, Pierre G.[UCL] Khammari, Amir Dreno, Brigitte Leccia, Marie-Thérèse Plumas, Joel (2020) Oncoimmunology — Vol. 9, no. 1, p. 1738812 (2020)